BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28919750)

  • 1. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.
    Yuan YG; Peng QL; Gurunathan S
    Int J Nanomedicine; 2017; 12():6487-6502. PubMed ID: 28919750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
    El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy.
    Zhang XF; Gurunathan S
    Int J Nanomedicine; 2016; 11():3655-75. PubMed ID: 27536105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells.
    Yuan YG; Gurunathan S
    Int J Nanomedicine; 2017; 12():6537-6558. PubMed ID: 28919753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells.
    Choi YJ; Park JH; Han JW; Kim E; Jae-Wook O; Lee SY; Kim JH; Gurunathan S
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3).
    Zhang XF; Huang FH; Zhang GL; Bai DP; Massimo DF; Huang YF; Gurunathan S
    Int J Nanomedicine; 2017; 12():7551-7575. PubMed ID: 29075115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Characterization of Folic Acid Conjugated Gemcitabine Tethered Silver Nanoparticles (FA-GEM-AgNPs) for Targeted Delivery.
    Karuppaiah A; Rajan R; Hariharan S; Balasubramaniam DK; Gregory M; Sankar V
    Curr Pharm Des; 2020; 26(26):3141-3146. PubMed ID: 32175835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells.
    Yuan YG; Zhang S; Hwang JY; Kong IK
    Oxid Med Cell Longev; 2018; 2018():6121328. PubMed ID: 30647812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
    Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
    Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity- and differentiation-mediated cancer therapy.
    Han JW; Gurunathan S; Choi YJ; Kim JH
    Int J Nanomedicine; 2017; 12():7529-7549. PubMed ID: 29066898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
    Yang Y; Tian W; Yang L; Zhang Q; Zhu M; Liu Y; Li J; Yang L; Liu J; Shen Y; Qi Z
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):93-103. PubMed ID: 32897433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
    Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic effect of the combination gemcitabine/topotecan in ovarian cancer cells.
    Distefano M; Ferlini C; De Vincenzo R; Gaggini C; Mancuso S; Scambia G
    Oncol Res; 2000; 12(9-10):355-9. PubMed ID: 11697814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer.
    Li L; Zhao SL; Yue GGL; Wong TP; Pu JX; Sun HD; Fung KP; Leung PC; Han QB; Lau CBS; Leung PS
    Phytomedicine; 2018 May; 44():56-64. PubMed ID: 29895493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.
    Larson N; Yang J; Ray A; Cheney DL; Ghandehari H; Kopeček J
    Int J Pharm; 2013 Sep; 454(1):435-43. PubMed ID: 23827653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noxa enhances the cytotoxic effect of gemcitabine in human ovarian cancer cells.
    Cao K; Yang J; Lin C; Wang BN; Yang Y; Zhang J; Dai J; Li L; Nie CL; Yuan Z; Li MY
    Cancer Biother Radiopharm; 2012 May; 27(4):259-66. PubMed ID: 22489660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effect of silver nanoparticles synthesized using amla on Hep2 cell line.
    Rosarin FS; Arulmozhi V; Nagarajan S; Mirunalini S
    Asian Pac J Trop Med; 2013 Jan; 6(1):1-10. PubMed ID: 23317879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis.
    Rodríguez-Razón CM; Yañez-Sánchez I; Ramos-Santillan VO; Velásquez-Ordóñez C; Gutiérrez-Rubio SA; García-García MR; López-Roa RI; Sánchez-Hernández PE; Daneri-Navarro A; García-Iglesias T
    Int J Nanomedicine; 2018; 13():1081-1095. PubMed ID: 29503542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling.
    Gong JH; Zheng YB; Zhang MR; Wang YX; Yang SQ; Wang RH; Miao QF; Liu XJ; Zhen YS
    Cancer Biol Ther; 2020 Apr; 21(4):332-343. PubMed ID: 31906826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients.
    Xiao Y; Gao Y; Li F; Deng Z
    Drug Deliv; 2020 Dec; 27(1):1491-1500. PubMed ID: 33100060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.